McAdam LLC’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,629
Closed -$925 337
2024
Q1
$925 Hold
25,629
﹤0.01% 302
2023
Q4
$10.6K Hold
25,629
﹤0.01% 274
2023
Q3
$26.4K Hold
25,629
﹤0.01% 252
2023
Q2
$49.5K Hold
25,629
﹤0.01% 255
2023
Q1
$20.8K Hold
25,629
﹤0.01% 250
2022
Q4
$65K Hold
25,629
0.01% 189
2022
Q3
$41K Hold
25,629
﹤0.01% 210
2022
Q2
$45K Hold
25,629
﹤0.01% 213
2022
Q1
$106K Hold
25,629
0.01% 204
2021
Q4
$65K Hold
25,629
0.01% 189
2021
Q3
$100K Buy
25,629
+1,200
+5% +$6K 0.01% 173
2021
Q2
$129K Hold
24,429
0.01% 169
2021
Q1
$198K Buy
24,429
+5,429
+29% +$49.8K 0.03% 153
2020
Q4
$169K Buy
+19,000
New +$129K 0.03% 156

Other funds holding GMDA

McAdam LLC's GMDA Position: Q2 2024 in Review

McAdam LLC sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 25,629 shares — an estimated $925 sold.

McAdam LLC first reported a position in GMDA in Q4 2020 and held it in 14 quarters. The position peaked at $198K in Q1 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

  • McAdam LLC reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • McAdam LLC sold 25,629 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $925.
  • McAdam LLC first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and held it in 14 quarters.
  • McAdam LLC's Gamida Cell Ltd. Ordinary Shares position peaked at $198K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on McAdam LLC's 13F filing for Q2 2024, filed 24 Jul 2024.